insights_auto
Outlook: 70.8% bullish·0.0% bearish
Go to analysischevron_right
VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$510.08
arrow_upward
+1.36%(+6.83) 1D
$510.08
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$502.11
High
$514.90
Low
$502.06
Mkt. cap
129.29B
Avg. vol.
1.01M
Volume
1.48M
P/E ratio
29.68
52-wk high
$560.25
52-wk low
$402.58
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
Open
$502.11
High
$514.90
Low
$502.06
Mkt. cap
129.29B
Avg. vol.
1.01M
Volume
1.48M
P/E ratio
29.68
52-wk high
$560.25
52-wk low
$402.58
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
Simply Wall Street
·
35 minutes ago
11% Undervalued? Vertex Pharmaceuticals (VRTX) Following New ALYFTREK Data
Zacks
·
10 hours ago
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
Yahoo Finance Australia
·
11 hours ago
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
AD HOC NEWS
·
14 hours ago
Vertex Pharma stock rises to EUR 455.50, P/ E 29.7 amid gains
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com